Bao Kang Wei
Chief Executive Officer bei SICHUAN GOLDSTONE ASIA PHARMACEUTICAL INC.
Profil
Bao Kang Wei is currently the Chairman & General Manager at Hainan Asia Pharmaceutical Co., Ltd., the Chairman & General Manager at Sichuan Goldstone Asia Pharmaceutical, Inc., and the Director at Zhejiang Jiande Zhengfa Pharmaceutical Co., Ltd.
Previously, he held positions as the Chairman at Beijing Tiantan Biological Products Corp.
Ltd., the Director at Shanghai Shyndec Pharmaceutical Co., Ltd., and the President at Shanghai Shyndec Pharmaceutical Co., Ltd.
Aktive Positionen von Bao Kang Wei
| Unternehmen | Position | Beginn |
|---|---|---|
| SICHUAN GOLDSTONE ASIA PHARMACEUTICAL INC. | Chief Executive Officer | 09.12.2019 |
Zhejiang Jiande Zhengfa Pharmaceutical Co., Ltd.
 Zhejiang Jiande Zhengfa Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sichuan Goldstone Asia Pharmaceutical, Inc., Zhejiang Jiande Zhengfa Pharmaceutical Co., Ltd. manufactures pharmaceutical products. The private company is based in Hangzhou, China. The Chinese company was founded in 1992. The CEO is Shu Ping Yang. Zhejiang Jiande Zhengfa Pharmaceutical Co. was acquired by Sichuan Goldstone Asia Pharmaceutical, Inc. on May 20, 2021 for $23.56 million. | Director/Board Member | - |
Hainan Asia Pharmaceutical Co., Ltd.
 Hainan Asia Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hainan Asia Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products and medical instruments. The firm also involves in the research and development of drug and biotechnology. The company was founded in 1991 and is headquartered in Haikou, China. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Bao Kang Wei
| Unternehmen | Position | Ende |
|---|---|---|
| SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Director/Board Member | 26.02.2020 |
| BEIJING TIANTAN BIOLOGICAL PRODUCTS CO., LTD. | Chairman | - |
| SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | President | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BEIJING TIANTAN BIOLOGICAL PRODUCTS CO., LTD. | Health Technology |
| SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Health Technology |
| SICHUAN GOLDSTONE ASIA PHARMACEUTICAL INC. | Producer Manufacturing |
| Private Unternehmen | 2 |
|---|---|
Hainan Asia Pharmaceutical Co., Ltd.
Hainan Asia Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hainan Asia Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products and medical instruments. The firm also involves in the research and development of drug and biotechnology. The company was founded in 1991 and is headquartered in Haikou, China. | Health Technology |
Zhejiang Jiande Zhengfa Pharmaceutical Co., Ltd.
Zhejiang Jiande Zhengfa Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sichuan Goldstone Asia Pharmaceutical, Inc., Zhejiang Jiande Zhengfa Pharmaceutical Co., Ltd. manufactures pharmaceutical products. The private company is based in Hangzhou, China. The Chinese company was founded in 1992. The CEO is Shu Ping Yang. Zhejiang Jiande Zhengfa Pharmaceutical Co. was acquired by Sichuan Goldstone Asia Pharmaceutical, Inc. on May 20, 2021 for $23.56 million. | Health Technology |
